Abstract:Nanotechnology has revolutionized cancer treatment in both diagnosis and therapy. Since the initial application of nanoparticles (NPs) in cancer treatment, the main objective of nanotechnology was developing effective nanosystems with high selectivity and specificity for cancer treatment and diagnosis. To achieve this, different encapsulation and conjugation strategies along with surface functionalization techniques have been developed to synthesize anticancer drugs loaded NPs with effective targeting to specific tumor cells. The unique physicochemical attributes of NPs make them promising candidates for targeted drug delivery, localized therapies, sensing, and targeting at cellular levels. However, a nanosystem for localized and targeted cancer managements should overcome several biological barriers and biomedical challenges such as endothelial barriers, blood brain barrier, reticuloendothelial system, selective targeting, biocompatibility, acute/chronic toxicity, tumor-targeting efficacy. The NPs for in vivo applications encounter barriers at system, organ, and the cellular level. To overcome these barriers, different strategies during the synthesis and functionalization of NPs should be adapted. Pharmacokinetics and cellular uptake of NPs are largely associated with physicochemical attributes of NPs, morphology, hydrodynamic size, charge, and other surface properties. These properties can be adjusted during different phases of synthesis and functionalization of the NPs. This study reviews the advances in targeted cancer treatment and the parameters influencing the efficacies of NPs as therapeutics. Different strategies for overcoming the biological barriers at cellular, organ and system levels and biomedical challenges are discussed. Moreover, the applications of NPs in preclinical and clinical practice are reviewed.

Influencing factors and strategies of enhancing nanoparticles into tumors in vivo

Strategies to improve tumor penetration of nanomedicines through nanoparticle design

The progress and perspective of strategies to improve tumor penetration of nanomedicines

Engineering nanoparticles to tackle tumor barriers

Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery

Size Shrinkable Drug Delivery Nanosystems and Priming the Tumor Microenvironment for Deep Intratumoral Penetration of Nanoparticles

Intratumoral Fate of Functional Nanoparticles in Response to Microenvironment Factor: Implications on Cancer Diagnosis and Therapy

Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies

Effect of biophysical properties of tumor extracellular matrix on intratumoral fate of nanoparticles: Implications on the design of nanomedicine

Multifunctional Nanoparticles in Precise Cancer Treatment: Considerations in Design and Functionalization of Nanocarriers.

"Targeting Design" of Nanoparticles in Tumor Therapy

Enhancing Drug Penetration in Solid Tumors Via Nanomedicine: Evaluation Models, Strategies and Perspectives

Radiation-assisted Strategies Provide New Perspectives to Improve the Nanoparticle Delivery to Tumor.

Exploring the tumor microenvironment with nanoparticles.

Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery

Recent Advances in Drug Delivery Systems for Enhancing Drug Penetration into Tumors

Shaping Tumor Microenvironment for Improving Nanoparticle Delivery

Tumor Microenvironment Regulation and Cancer Targeting Therapy Based on Nanoparticles

Nanoparticle Design Strategies for Enhanced Anticancer Therapy by Exploiting the Tumour Microenvironment.

Competition Between Tumor and Mononuclear Phagocyte System Causing the Low Tumor Distribution of Nanoparticles and Strategies to Improve Tumor Accumulation.

Enhancing X‐Ray Sensitization with Multifunctional Nanoparticles